A. Pathan

发表

Complement Deposition on Nanoparticles Can Modulate Immune Responses by Macrophage, B and T Cells.

Robert B Sim, U. Kishore, B. Ten Haken, 2016, Journal of Biomedical Nanotechnology.

Human C1q Induces Apoptosis in an Ovarian Cancer Cell Line via Tumor Necrosis Factor Pathway

E. Karteris, U. Kishore, F. Alhamlan, 2016, Front. Immunol..

Th1/Th17 Cell Induction and Corresponding Reduction in ATP Consumption following Vaccination with the Novel Mycobacterium tuberculosis Vaccine MVA85A

H. McShane, A. Hill, H. Fletcher, 2011, PloS one.

Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.

A. Hill, W. Ballou, M. Plebanski, 1999, The Journal of infectious diseases.

Induction of CD152 (CTLA-4) and LAP (TGF-β1) in human Foxp3- CD4+ CD25- T cells modulates TLR-4 induced TNF-α production.

Roger Williams, S. Pereira, S. Behboudi, 2013, Immunobiology.

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-β1

H. McShane, A. Hill, H. Fletcher, 2008, Vaccine.

CD8+ T cell‐mediated suppression of intracellular Mycobacterium tuberculosis growth in activated human macrophages

H. McShane, A. Hill, R. Brookes, 2003, European journal of immunology.

Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis.

D. Webster, H. McShane, A. Hill, 2006, Vaccine.

Unmasking of α-Fetoprotein-Specific CD4+ T Cell Responses in Hepatocellular Carcinoma Patients Undergoing Embolization1

A. Burroughs, Roger Williams, T. Meyer, 2007, The Journal of Immunology.

The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal priming

P. Klenerman, A. Hill, S. Todryk, 2009, Immunology.

Human CD4+ T Cells Recognize an Epitope within α-Fetoprotein Sequence and Develop into TGF-β-Producing CD4+ T Cells1

Roger Williams, S. Behboudi, L. Ayaru, 2008, The Journal of Immunology.

Secretion of functionally active complement factor H related protein 5 (FHR5) by primary tumour cells derived from Glioblastoma Multiforme patients.

H. Khan, S. Alrokayan, U. Kishore, 2019, Immunobiology.

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A

H. McShane, A. Hill, H. Fletcher, 2011, PLoS ONE.

Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials

H. McShane, A. Hill, H. Fletcher, 2011, PLoS ONE.

Analysis of CD4+ T-Cell Responses to a Novel α-Fetoprotein-Derived Epitope in Hepatocellular Carcinoma Patients

Roger Williams, A. Bertoletti, S. Behboudi, 2005, Clinical Cancer Research.

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.

H. McShane, A. Hill, H. Fletcher, 2005, Tuberculosis.

Human T cell responses to the antigen ESAT-6 characterize vaccine candidate and potential diagnostic test for tuberculosis

R. Wilkinson, A. Hill, A. Lalvani, 1999 .

Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials

H. McShane, A. Hill, H. Fletcher, 2007, PloS one.

A Recombinant Fragment of Human Surfactant Protein D Suppresses Basophil Activation and T‐Helper Type 2 and B‐Cell Responses in Grass Pollen‐induced Allergic Inflammation

S. Durham, U. Kishore, M. Shamji, 2017, American journal of respiratory and critical care medicine.

Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivity.

E. Makarov, M. Al-Ahdal, U. Kishore, 2019, Immunobiology.

Diagnosis of tuberculosis in South African children with a T cell-based assay: a prospective cohort study

Ajit Lalvani, J. Deeks, A. Lalvani, 2004, The Lancet.

Direct Growth Inhibitory Effect of Platelet Activating Factor C-16 and Its Structural Analogs on Mycobacteria

S. Behboudi, U. Kishore, A. Pathan, 2018, Front. Microbiol..

Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians.

A. Hill, A. Lalvani, K. Wilkinson, 2001, The Journal of infectious diseases.

Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells

H. Ayles, A. Lalvani, P. Godfrey-Faussett, 2002, AIDS.

Association of Marek’s Disease induced immunosuppression with activation of a novel regulatory T cells in chickens

S. Behboudi, B. Kaufer, A. Pathan, 2017, PLoS pathogens.

Marek’s Disease Virus Modulates T Cell Proliferation via Activation of Cyclooxygenase 2-Dependent Prostaglandin E2

S. Behboudi, B. Kaufer, A. Pathan, 2021, Frontiers in Immunology.

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

D. Webster, R. Sinden, T. Peto, 2003, Nature Medicine.

Analysis of the Interaction between Globular Head Modules of Human C1q and Its Candidate Receptor gC1qR

H. Khan, U. Kishore, E. Peerschke, 2016, Front. Immunol..

Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A

H. McShane, A. Hill, H. Fletcher, 2009, PloS one.

Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells

J. Deeks, A. Hill, A. Lalvani, 2001, The Lancet.

Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis.

H. Dockrell, R. Wilkinson, A. Hill, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populations

R. Koup, D. Douek, D. Ambrozak, 2007, European journal of immunology.

Entry Inhibition and Modulation of Pro-Inflammatory Immune Response Against Influenza A Virus by a Recombinant Truncated Surfactant Protein D

B. Nal, M. Al-Ahdal, U. Kishore, 2018, Front. Immunol..

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

H. McShane, A. Hill, H. Fletcher, 2004, Nature Medicine.

Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis.

P. Klenerman, R. Davies, N. Maskell, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells.

R. Wilkinson, H. McShane, A. Hill, 2001, American journal of respiratory and critical care medicine.

Dissecting the Mechanism of Intracellular Mycobacterium smegmatis Growth Inhibition by Platelet Activating Factor C-16

S. Behboudi, U. Kishore, A. Pathan, 2020, Frontiers in Microbiology.

Human Properdin Modulates Macrophage: Mycobacterium bovis BCG Interaction via Thrombospondin Repeats 4 and 5

E. Makarov, Robert B Sim, M. Al-Ahdal, 2018, Front. Immunol..

Direct Ex Vivo Analysis of Antigen-Specific IFN-γ-Secreting CD4 T Cells in Mycobacterium tuberculosis-Infected Individuals: Associations with Clinical Disease State and Effect of Treatment1

P. Klenerman, H. McShane, A. Hill, 2001, The Journal of Immunology.

Roles for Treg Expansion and HMGB1 Signaling through the TLR1-2-6 Axis in Determining the Magnitude of the Antigen-Specific Immune Response to MVA85A

H. McShane, Joel Meyer, H. Fletcher, 2013, PloS one.

Identification of Major Factors Influencing ELISpot-Based Monitoring of Cellular Responses to Antigens from Mycobacterium tuberculosis

Tom H. M. Ottenhoff, Hazel M. Dockrell, F. Mascart, 2009, PloS one.

A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity

H. McShane, A. Lawrie, A. Minassian, 2012 .

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults

H. McShane, A. Hill, H. Fletcher, 2012, Vaccine.

High frequencies of circulating IFN‐γ‐secreting CD8 cytotoxic T cells specific for a novel MHC class I‐restricted Mycobacterium tuberculosis epitope in M. tuberculosis‐infected subjects without disease

R. Wilkinson, H. McShane, A. Hill, 2000 .

Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A

T. Scriba, W. Hanekom, H. Mahomed, 2014, BMC Infectious Diseases.

Investigating the Induction of Vaccine-Induced Th17 and Regulatory T Cells in Healthy, Mycobacterium bovis BCG-Immunized Adults Vaccinated with a New Tuberculosis Vaccine, MVA85A

H. McShane, A. Hill, H. Fletcher, 2010, Clinical and Vaccine Immunology.

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.

R. Davies, F. Gleeson, H. McShane, 2009, American journal of respiratory and critical care medicine.

A comparison of IFNgamma detection methods used in tuberculosis vaccine trials.

H. Dockrell, T. Scriba, W. Hanekom, 2008, Tuberculosis.

Analysis of CD 4 + T-Cell Responses to a Novel A-Fetoprotein-Derived Epitope in Hepatocellular Carcinoma Patients

Roger Williams, A. Bertoletti, S. Behboudi, 2005 .

Disease State and Effect of Treatment Individuals : Associations with Clinical-Infected Mycobacterium tuberculosis-Secreting CD 4 T Cells in γ IFN-Direct Ex Vivo Analysis of Antigen-Specific

P. Klenerman, H. McShane, A. Hill, 2001 .

Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults

H. McShane, A. Lawrie, A. Hill, 2012, Human vaccines & immunotherapeutics.

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults

A. Winston, R. Koup, D. Douek, 2011, BMJ Open.

Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease

R. Williams, S. Behboudi, S. Boswell, 2010, British Journal of Cancer.

Au coated Ni nanowires with tuneable dimensions for biomedical applications.

A. W. Maijenburg, J. E. ten Elshof, U. Kishore, 2013, Journal of materials chemistry. B.

Investigating the Induction of Vaccine-Induced Th17 and Regulatory T Cells in Healthy, Mycobacterium bovis BCG Immunized Adults Vaccinated with a New Tuberculosis Vaccine, MVA85A

H. McShane, A. Hill, H. Fletcher, 2011, Clinical and Vaccine Immunology.

Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status.

Richard G. White, T. Scriba, H. McShane, 2016, Tuberculosis.

Using Data from Macaques To Predict Gamma Interferon Responses after Mycobacterium bovis BCG Vaccination in Humans: a Proof-of-Concept Study of Immunostimulation/Immunodynamic Modeling Methods

Richard G. White, H. McShane, H. Fletcher, 2017, Clinical and Vaccine Immunology.

Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors.

A. Hill, S. Rowland-Jones, G. Ogg, 1997, Journal of immunological methods.

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults

R. Koup, D. Ambrozak, J. Casazza, 2011, BMJ Open.